We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-20.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.64B
AUM Growth
+$440M
Cap. Flow
+$940M
Cap. Flow %
57.18%
Top 10 Hldgs %
44.47%
Holding
4,515
New
888
Increased
1,264
Reduced
882
Closed
1,360

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$101M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$93.9M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$93M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$45.3M
5
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$33.1M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$87.2M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$19.8M
3
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.9M
5
IWN icon
iShares Russell 2000 Value ETF
IWN
+$13.3M

Sector Composition

Rank Sector Weight
1 Financials 4.56%
2 Industrials 3.56%
3 Consumer Discretionary 3.21%
4 Technology 3.1%
5 Healthcare 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGLE
2101
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$9K ﹤0.01%
689
+406
+143% +$9.03K
PDLI
2102
DELISTED
PDL BioPharma, Inc.
PDLI
$9K ﹤0.01%
3,345
+664
+25% +$2.14K
ANIX icon
2103
Anixa Biosciences
ANIX
$109M
$8K ﹤0.01%
5,162
-955
-16% -$2.8K
APYX icon
2104
Apyx Medical
APYX
$128M
$8K ﹤0.01%
+2,204
New +$14.8K
AROC icon
2105
Archrock
AROC
$5.85B
$8K ﹤0.01%
2,056
+621
+43% +$4.49K
BW icon
2106
Babcock & Wilcox
BW
$1.39B
$8K ﹤0.01%
7,519
+7,459
+12,432% +$26.9K
BXC icon
2107
BlueLinx
BXC
$705M
$8K ﹤0.01%
+1,571
New +$17.7K
CDE icon
2108
Coeur Mining
CDE
$19B
$8K ﹤0.01%
+2,543
New +$13.2K
CLDX icon
2109
Celldex Therapeutics
CLDX
$3.35B
$8K ﹤0.01%
4,843
+54
+1% +$122
CVEO icon
2110
Civeo
CVEO
$344M
$8K ﹤0.01%
1,575
-760
-33% -$10.1K
CYCN icon
2111
Cyclerion Therapeutics
CYCN
$18.3M
$8K ﹤0.01%
+146
New +$10.4K
DNOW icon
2112
DNOW Inc
DNOW
$2.95B
$8K ﹤0.01%
1,594
-3,387
-68% -$30.5K
DYAI icon
2113
Dyadic International
DYAI
$28.1M
$8K ﹤0.01%
1,399
-2,454
-64% -$12.9K
ELP
2114
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$8K ﹤0.01%
1,923
-2,085
-52% -$12.8K
EVC icon
2115
Entravision Communication
EVC
$820M
$8K ﹤0.01%
3,994
+2,470
+162% +$5.21K
EVI icon
2116
EVI Industries
EVI
$209M
$8K ﹤0.01%
491
+383
+355% +$8.61K
FNB icon
2117
FNB Corp
FNB
$6.88B
$8K ﹤0.01%
1,049
+612
+140% +$6.46K
GSAT icon
2118
Globalstar
GSAT
$10.7B
$8K ﹤0.01%
1,744
-27
-2% -$175
GYRE icon
2119
Gyre Therapeutics
GYRE
$693M
$8K ﹤0.01%
220
-138
-39% -$6.34K
HROW icon
2120
Harrow
HROW
$1.46B
$8K ﹤0.01%
2,170
-5,984
-73% -$35.4K
HTHT icon
2121
Huazhu Hotels Group
HTHT
$12.5B
$8K ﹤0.01%
+286
New +$9.73K
MTEX icon
2122
Mannatech
MTEX
$11.9M
$8K ﹤0.01%
777
+40
+5% +$548
PWZ icon
2123
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.18B
$8K ﹤0.01%
301
– –
QGEN icon
2124
Qiagen
QGEN
$8.93B
$8K ﹤0.01%
189
-5,367
-97% -$210K
RELL icon
2125
Richardson Electronics
RELL
$300M
$8K ﹤0.01%
2,141
+609
+40% +$2.95K
83 84
85
86 87

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2020 Portfolio in Review

As of Q1 2020, Tower Research Capital (TRC) held 4,515 positions worth $1.64B, up 37% from $1.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tower Research Capital (TRC) deployed $940M of net new capital in Q1 2020, opening 888 new positions and adding to 1,264 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 2.5% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $87.2M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2020 buy was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $101M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $87.2M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2020, selling an estimated $19.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 44% of its $1.64B portfolio in Q1 2020.
  • Tower Research Capital (TRC) opened 888 new positions and closed 1,360 in Q1 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.64B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2020, filed 15 May 2020.